Literature DB >> 9810692

Na(+)-glucose cotransporter inhibitors as antidiabetic agents. III. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives modified at the OH groups of the glucose moiety.

M Hongu1, N Funami, Y Takahashi, K Saito, K Arakawa, M Matsumoto, H Yamakita, K Tsujihara.   

Abstract

To overcome hydrolysis by beta-glucosidase present in the digestive tract, the OH groups on the glucose moiety of the 4'-dehydroxyphlorizin derivatives (1, 2, 3) were modified with various kinds of patterns, and then the effects of the modified compounds on urinary glucose excretion were evaluated in rats. Among them, triacetyl (9), 2,3-O-diacetyl (17), 6-O-methoxycarbonyl (34), 4-O-methoxycarbonyl (38), and 2-O-acetyl (41) derivatives showed more potent effect than the parent compound 2 by oral administration (p.o.). The stabilities of the compounds 34, 38, and 41 against beta-glucosidase were higher than that of 2. The increase in oral activity was found to correlate with the enhancement of the stability against beta-glucosidase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810692     DOI: 10.1248/cpb.46.1545

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

1.  Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Authors:  K Arakawa; T Ishihara; A Oku; M Nawano; K Ueta; K Kitamura; M Matsumoto; A Saito
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class.

Authors:  Paula Nogueira da Silva; Raissa Alves da Conceição; Rodolfo do Couto Maia; Maria Leticia de Castro Barbosa
Journal:  Medchemcomm       Date:  2018-06-06       Impact factor: 3.597

3.  A 96-well automated method to study inhibitors of human sodium-dependent D-glucose transport.

Authors:  Francisco Castaneda; Rolf K-H Kinne
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

4.  Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes.

Authors:  Francisco Castaneda; Antje Burse; Wilhelm Boland; Rolf K-H Kinne
Journal:  Int J Med Sci       Date:  2007-05-05       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.